Advance Biofactures Corp

Jay Group is an award-winning, 3rd generation, family-owned and -operated 3pl logistics provider. Some of the world's most trusted and well-known brands across the U.S. have relied on Jay Group since 1965. Jay Group has even been chosen as one of Inc. 5000's fastest-growing private companies. As an industry-leading provider of warehouse inventory management, eCommerce fulfillment, and specialty packaging services, Jay Group ensures your product is delivered on-time and accurately (inventory accuracy rates of 99.9%). Seamless eCommerce integrations, Business Intelligence software and the latest Warehouse Management Systems from Manhattan Associates make Jay Group a strategic choice as your 3pl partner. Start your fulfillment journey.

Located in the vibrant city of Wilmington, DE, Novartis Corp offers top-notch freight forwarding services that cater to a diverse range of logistical needs. With a strategic location that facilitates efficient transportation, Novartis Corp stands out as a reliable partner for businesses looking to streamline their supply chain operations. At Novartis Corp, a dedicated team of professionals ensures that each shipment is handled with precision and care, guaranteeing timely deliveries and optimal routing solutions. Whether you are shipping goods domestically or internationally, Novartis Corp's comprehensive freight forwarding services are designed to meet your specific requirements and exceed your expectations. Generated using this place's available information

Accolade Pharmaceuticals is a development-stage specialty biopharmaceutical company based in Wilmington, DE, focused on creating innovative treatments for atopic and inflammatory allergic conditions. The company is dedicated to re-purposing zafirlukast, a well-known Leukotriene Receptor Antagonist (LTRA) that is already approved and marketed worldwide under the name Accolate. By leveraging their expertise, Accolade Pharmaceuticals aims to offer promising new therapies for individuals suffering from allergic disorders. Their commitment to improving patient outcomes drives their research and development initiatives in the field of allergy treatments. Generated from the website